Evidence map›Paper›PMID 37446557›Full record

ArticleMolecules (Basel, Switzerland)2023

Comparing the Colloidal Stabilities of Commercial and Biogenic Iron Oxide Nanoparticles That Have Potential In Vitro/In Vivo Applications.

Jonas Schwan, Simon Markert, Sabine Rosenfeldt, Dirk Schüler, Frank Mickoleit, Anna S Schenk

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Eco-friendly synthesis of FeFrontiers in microbiology · 2026
    Article
  3. Article
  4. Review
  5. Antibacterial Activity of CuO Nanoparticles, Ethanolic Extract ofInternational journal of nanomedicine · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jonas SchwanPhysical Chemistry IV, University of Bayreuth, D-95447 Bayreuth, Germany.
Simon MarkertDepartment Microbiology, University of Bayreuth, D-95447 Bayreuth, Germany.ORCID 0009-0001-2165-7226
Sabine RosenfeldtPhysical Chemistry I, University of Bayreuth, D-95447 Bayreuth, Germany.
Dirk SchülerDepartment Microbiology, University of Bayreuth, D-95447 Bayreuth, Germany.ORCID 0000-0002-2327-0762
Frank MickoleitDepartment Microbiology, University of Bayreuth, D-95447 Bayreuth, Germany.ORCID 0000-0002-1943-3960
Anna S SchenkPhysical Chemistry IV, University of Bayreuth, D-95447 Bayreuth, Germany.ORCID 0000-0001-5637-1255

Funding

European Research Council 692637
6 · The paper itself

Abstract

For the potential in vitro/in vivo applications of magnetic iron oxide nanoparticles, their stability in different physiological fluids has to be ensured. This important prerequisite includes the preservation of the particles' stability during the envisaged application and, consequently, their invariance with respect to the transfer from storage conditions to cell culture media or even bodily fluids. Here, we investigate the colloidal stabilities of commercial nanoparticles with different coatings as a model system for biogenic iron oxide nanoparticles (magnetosomes) isolated from magnetotactic bacteria. We demonstrate that the stability can be evaluated and quantified by determining the intensity-weighted average of the particle sizes (

Indexed as

MagnetosomesNanoparticlesMagnetic Iron Oxide Nanoparticlescolloidal stabilitymagnetic nanoparticlesmagnetosomesprotein corona

Identifiers

PMID37446557
PMCPMC10343720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.